3SBio, Ascentage Enter Into Strategic Alliance
The alliance is expected to leverage Ascentage’s expertise in structure-based small molecule design, lead optimisation and preclinical development with 3SBio’s proven drug development and commercialisation capabilities in China.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.